Collegium to Present at Upcoming Investor Conferences
- The Oppenheimer & Company 28th Annual Healthcare Conference on
Wednesday, March 21st at 9:10 a.m. ETin New York City
- The Needham 17th Annual Healthcare Conference on
Wednesday, March 28th at 10:30 a.m. ETin New York City
Collegium is a specialty pharmaceutical company focused on becoming the leader in responsible pain management by developing and commercializing innovative, differentiated products for patients suffering from pain.
About Xtampza ER
Xtampza® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the
Source: Collegium Pharmaceutical, Inc.